Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 09, 2023

BUY
$4.45 - $7.57 $393,224 - $668,923
88,365 New
88,365 $480,000
Q1 2021

May 17, 2021

SELL
$14.52 - $23.53 $152,460 - $247,065
-10,500 Closed
0 $0
Q4 2019

Feb 10, 2020

SELL
$13.01 - $17.15 $6,505 - $8,575
-500 Reduced 4.55%
10,500 $148,000
Q3 2019

Nov 06, 2019

BUY
$14.55 - $20.56 $160,050 - $226,160
11,000 New
11,000 $180,000

Others Institutions Holding OMER

About OMEROS CORP


  • Ticker OMER
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,730,000
  • Market Cap $465M
  • Description
  • Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...
More about OMER
Track This Portfolio

Track Cetera Advisors LLC Portfolio

Follow Cetera Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cetera Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cetera Advisors LLC with notifications on news.